White House: It is unacceptable for states to restrict access to abortion pills

Published Date: 08 Mar 2023

The White House said Friday it was "dangerous and unacceptable" for elected officials to target women's access to federally-approved abortion pills.

Read Full News

Latest News

GSK Sees Blockbuster Potential in Targeted Cancer Therapy After Promising Early Data

British drugmaker GSK's experimental targeted cancer drug Mo-rez has blockbuster potential, its head of oncology ⁠research has told reporters, after early data showed the...

Mail-order Dominates US Abortion Pill Dispensing

U.S. pharmacies are largely filling prescriptions for the abortion pill mifepristone via mail-order in states permitting telehealth access to the medication, despite ⁠a...

Menopausal Women in Canada Face Multiple Barriers to Care

Wait times of 2 or more years, difficulty recognizing menopausal symptoms, dismissive doctors, and lack of workplace support are among the hurdles women encounter.

Urgent Care Clinics Fill Abortion Care Gaps in Rural Areas

Communities are coming up with alternatives after the closing of several abortion clinics.

Extending Postpartum Monitoring Reduces Severe Complications

Extending the surveillance period past the delivery period to 6 weeks postpartum would align with World Health Organization practices.

Mosaicism Reporting Lacks Predictive Value for Live Birth

Use of mosaicism as measured by preimplantation genetic testing for aneuploidy does not predict chances of live birth after IVF.

Todays Updates

Where Does Mistletoe Extract Fit in Supportive Cancer Care?

Mistletoe therapy may improve the QOL of patients with cancer; however, evidence does not support a survival benefit, limiting its role in routine oncology care.

A Chemo-Free Option for Some Advanced Endometrial Cancers?

A phase 2 study suggests that immunotherapy plus radiation could spare some patients with advanced endometrial cancer from chemotherapy.

Todays Updates

Where Does Mistletoe Extract Fit in Supportive Cancer Care?

Mistletoe therapy may improve the QOL of patients with cancer; however, evidence does not support a survival benefit, limiting its role in routine oncology care.

A Chemo-Free Option for Some Advanced Endometrial Cancers?

A phase 2 study suggests that immunotherapy plus radiation could spare some patients with advanced endometrial cancer from chemotherapy.

Latest News

British drugmaker GSK's experimental targeted cancer drug Mo-rez has blockbuster potential, its head of oncology ⁠research has told reporters, after early data showed the...

U.S. pharmacies are largely filling prescriptions for the abortion pill mifepristone via mail-order in states permitting telehealth access to the medication, despite ⁠a...

Wait times of 2 or more years, difficulty recognizing menopausal symptoms, dismissive doctors, and lack of workplace support are among the hurdles women encounter.

Communities are coming up with alternatives after the closing of several abortion clinics.

Extending the surveillance period past the delivery period to 6 weeks postpartum would align with World Health Organization practices.

Use of mosaicism as measured by preimplantation genetic testing for aneuploidy does not predict chances of live birth after IVF.

News All Time

South Korea Birthrate Rises Amid Signs of Easing Demographic Crisis

South Korea's birthrate rose for a second straight year in 2025, signalling that the country facing a demographic crisis for nearly a decade may be starting to turn a corner.

Preterm Birth Linked to Higher Disability Risk at Age 12

Children born extremely premature may have higher rates of neurodevelopmental disorders and impairments in cognitive, motor, and behavioral functions, according to a new study.

New Hospital Price Data Benefit Insurers More Than Patients

Trump made hospitals post prices so patients could shop, but the data are scarce and insurers, not patients, use these to bargain.

Is Chemsex’s Impact on Mental Health Underestimated?

Beyond sexual health risks, chemsex is linked to serious mental health consequences influenced by how often, how intensely and how substances are used.

Older C-Section Surgical Technique May Reduce Complications

As the number of cesarean sections has increased over the past 30 years, a faster surgical closure technique has gained widespread use but may increase long-term complications.

Menstruation topic still stigmatized by younger generation in Spain, study finds

The menstrual taboo persists. This is the main conclusion of a pioneering macro-study in Spain involving more than 4,000 participants and led by the INGENIO Institute, a joint center of the Spanish National Research Council ...

Research team develops actionable tool to assess risk for premature births

Researchers at NYU and partners within the International Healthy Outcomes of Pregnancy for Everyone (HOPE) Consortium have developed a novel tool, the Preterm Birth Actionable Risk Index (PTB-ARIx), designed to identify pregnant ...

AHA: Study examines impact of adequate prenatal care for congenital heart disease

For cases of mild congenital heart defects (CHDs), more prenatal visits are associated with lower probability of delivery at a cardiac center, according to a study published online Nov. 9 in JAMA Network Open to coincide ...

Severe nausea during pregnancy and depression: Study reveals bidirectional association

A recent study conducted at the University of Turku in Finland showed that hyperemesis gravidarum, a severe form of nausea that occurs during pregnancy, is linked to depression. Women who experienced severe nausea were more ...

Common cesarean closure method linked to long-term complications, experts suggest change

The most common technique used for closing the uterus after a cesarean delivery causes so many long-term complications that it's time to question its use. That's the conclusion reached by two world-renowned specialists in ...

From post-partum depression to relationship woes: The importance of mental health after giving birth

"Postpartum depression" has been discussed as an identifiable, measurable, treatable disorder for 50 years now. Thresholds, scales, prevalence rates: everything seems clear, even reassuring.

Researchers call for greater clarity around prenatal screening forms

A new Australian study has found that forms used for one of the most common genetic screening tests in pregnancy—costing prospective parents up to $550—are often confusing and inconsistent, blurring the lines between ...

Pain during a C-section? New study challenges fears about general anesthesia

Regional anesthesia—typically with a spinal or epidural block—has long been favored for cesarean births due in part to concerns about the effects that general anesthesia may have on newborns during labor and delivery. ...

Majority of Georgia women surveyed would support abortion at 14 weeks, beyond the current legal limit

Among a cross-sectional group of women of reproductive age in Georgia, 76% supported the legality of abortion access at six weeks and 60% supported it at 14 weeks, according to a new study published in the open-access journal ...

Self-guided hypnosis can significantly reduce menopausal hot flashes

Can a simple daily audio hypnosis session help women find relief from one of menopause's most disruptive symptoms—hot flashes—without medication? A new clinical trial led by Baylor University's Gary R. Elkins, Ph.D., ...

Why anti-estrogen therapy fails in ovarian cancer, and how to make it work

Scientists at The Wistar Institute have solved a longstanding puzzle in ovarian cancer treatment: why anti-estrogen therapy often fails even when tumors express the hormone receptor that should make them responsive. The study ...

Recommended News For You

TCL1A Protein Identified as Predictor of Blinatumomab Response in Relapsed B-ALL

Overdosing on Chemotherapy: A Single Gene Test Could Prevent Hundreds of Deaths Annually.

Study reveals increase in late-stage breast cancer diagnoses in US

Silibinin is a novel and ancient molecule that highlights the significance of integrated therapies for cancer.

Cancer Diagnoses Still Lagging; Cancer and Family Health; New Type of Lung Cancer

Applications are being accepted for TN Health's post-doctoral fellowship program in gynecologic oncology and minimal access surgery; complete details are available here.

'Significant Milestone' for Radionuclide Therapy in Refractory Meningioma

Recommended Articles For You

A Comprehensive Guide to Living with Cutaneous T Cell Lymphoma: Tips & Strategies  

Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers 

New Research on Craniopharyngioma  

Partial Gland Ablation in Prostate Cancer: Oncologic Outcomes in Intermediate-Risk Cases 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Reversing the toxic relationship with high doses of chemotherapy in oncology.

2.

FDA OKs Upfront Nivolumab+Chemo for Classic Hodgkin Lymphoma

3.

Radiation therapy for patients with breast cancer

4.

Unified Neuro/Psych Residency Program: New Proposal.

5.

How access to specialized cancer centers affects glioblastoma outcomes

1.

Transforming Cancer Care: Metrics, Informatics, Equity, and Real-World Evidence

2.

Advances in Cancer Detection: From Genetic Risk to Molecular Biomarkers

3.

Unveiling the Hidden Benefits of Lymphedema Treatment

4.

Strategic Deals and FDA Approvals Transforming U.S. Oncology Drug Development

5.

Unlocking the Mysteries of Lymphoblastic Lymphoma: A Journey Into the Unknown

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.

2.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

3.

Navigating the Complexities of Ph Negative ALL - Part II

4.

INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients

5.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot